Forvis Mazars Wealth Advisors’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161M Buy
3,346,333
+303,401
+10% +$14.6M 2.65% 6
2026
Q2
$145M Buy
3,042,932
+342,747
+13% +$15.7M 2.42% 8
2026
Q1
$110M Buy
2,700,185
+403,204
+18% +$17.2M 2.1% 10
2025
Q4
$98.3M Buy
2,296,981
+437,719
+24% +$18.6M 1.86% 10
2025
Q3
$77.9M Buy
1,859,262
+382,500
+26% +$15.4M 1.55% 10
2025
Q2
$57.4M Buy
1,476,762
+527,957
+56% +$19M 1.24% 13
2025
Q1
$33.4M Buy
948,805
+557,959
+143% +$20.7M 0.8% 23
2024
Q4
$14.4M Buy
390,846
+98,875
+34% +$3.67M 0.33% 47
2024
Q3
$10.5M Buy
291,971
+122,596
+72% +$4.26M 0.24% 53
2024
Q2
$5.82M Buy
169,375
+100,150
+145% +$3.29M 0.15% 80
2024
Q1
$2.27M Buy
+69,225
New +$2.15M 0.06% 152

Other funds holding TSPA

Forvis Mazars Wealth Advisors's TSPA Position: Q3 2026 in Review

Forvis Mazars Wealth Advisors increased its T. Rowe Price US Equity Research ETF (TSPA) stake by 10% in Q3 2026, buying an estimated $14.6M and bringing the position to 3,346,333 shares worth $161M. The position accounts for 2.65% of the portfolio, ranked #6.

Forvis Mazars Wealth Advisors first reported a position in TSPA in Q1 2024 and has held it in 11 quarters since. 78 funds tracked by Wall St. Rank hold TSPA as of Q3 2026.

  • Forvis Mazars Wealth Advisors held 3,346,333 shares of T. Rowe Price US Equity Research ETF worth $161M as of Q3 2026.
  • Forvis Mazars Wealth Advisors bought 303,401 T. Rowe Price US Equity Research ETF shares in Q3 2026, an estimated $14.6M.
  • T. Rowe Price US Equity Research ETF made up 2.65% of Forvis Mazars Wealth Advisors's portfolio in Q3 2026, its #6 holding.
  • Forvis Mazars Wealth Advisors first reported a position in T. Rowe Price US Equity Research ETF in Q1 2024 and has held it in 11 quarters since.
  • 78 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q3 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.